FS
Simonetta, Federico
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney International Reports |  | 2025 | 91 | 101 | ||
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | | 2025 | 46 | 49 | ||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | | 2025 | 43 | 42 | ||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | | 2025 | 63 | 75 | ||
| Time-of-day dependency of adoptive cell therapies | Trends in cancer | | 2025 | 1 | 0 | ||
| Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation |  | 2024 | 79 | 0 | ||
| Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia : a case report | Frontiers in immunology | | 2024 | 33 | 35 | ||
| Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case report | Frontiers in immunology | | 2024 | 54 | 64 | ||
| Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT | Bone marrow transplantation | | 2024 | 47 | 0 | ||
| Molecular imaging of acute graft-versus-host disease | The Journal of nuclear medicine | | 2024 | 81 | 90 | ||
| A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacy | Molecular therapy. Oncology | | 2024 | 132 | 105 | ||
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | | 2024 | 939 | 230 | ||
| Severe anaphylaxis after chimeric antigen receptor T-cell injection : a case report | EJHaem | | 2024 | 51 | 67 | ||
| Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation : From Graft-versus-Host Disease to the Graft-versus-Tumor Effect | Transplantation and cellular therapy | | 2024 | 70 | 102 | ||
| Id3 keeps the PD-1 checkpoint in check in GVHD | Blood | | 2024 | 54 | 0 | ||
| Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies : basic considerations and best practice recommendations from the EBMT | The lancet. Haematology | | 2024 | 75 | 0 | ||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | | 2024 | 60 | 77 | ||
| How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? | Hematological oncology | | 2024 | 107 | 60 | ||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | | 2024 | 44 | 72 | ||
| Single-cell transcriptomics reveal different maturation stages and sublineage commitment of human thymic invariant natural killer T cells | Journal of leukocyte biology | | 2024 | 92 | 54 | ||
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | | 2024 | 513 | 420 | ||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | | 2024 | 53 | 84 | ||
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | | 2024 | 107 | 52 | ||
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | | 2024 | 138 | 56 | ||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | | 2023 | 155 | 41 | ||
| Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivo | Blood | | 2023 | 72 | 21 | ||
| Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption | Frontiers in oncology | | 2023 | 66 | 57 | ||
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | | 2023 | 72 | 37 | ||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | | 2023 | 73 | 105 | ||
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | | 2023 | 72 | 24 | ||
| Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | | 2023 | 150 | 84 | ||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | | 2023 | 86 | 54 | ||
| Multimodal Immunomonitoring of Hematopoietic Stem Cell Transplantation and Cellular Therapies for Hematological Malignancies | | 2023 | 92 | 206 | |||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | | 2023 | 137 | 63 | ||
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | | 2022 | 182 | 75 | ||
| An epigenetic signature in CD19-CAR T cells predicts clinical outcome | Trends in cancer | | 2022 | 183 | 0 | ||
| Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation | Frontiers in immunology | | 2022 | 111 | 60 | ||
| Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD | Blood | | 2022 | 493 | 113 | ||
| A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study | Transplant international | | 2022 | 208 | 102 | ||
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | | 2022 | 147 | 130 | ||
| Killers on the loose : Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment | International review of cell and molecular biology | | 2022 | 56 | 0 | ||
| IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor | American journal of transplantation | | 2022 | 46 | 70 | ||
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | | 2022 | 135 | 108 | ||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | 2022 | 240 | 102 | ||
| ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD | Blood advances | | 2022 | 175 | 254 | ||
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | | 2022 | 134 | 53 | ||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | 2022 | 255 | 84 | ||
| Multiparameter longitudinal imaging of immune cell activity in chimeric antigen receptor T cell and checkpoint blockade therapies | ACS central science | | 2022 | 53 | 17 | ||
| Dual cytokine blockade in acute GVHD | Blood | | 2021 | 204 | 1 | ||
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation | | 2021 | 346 | 0 | ||
| Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation | Frontiers in immunology | | 2021 | 165 | 140 | ||
| Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming | Clinical cancer research | | 2021 | 207 | 135 | ||
| Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET | Clinical cancer research | | 2021 | 225 | 140 | ||
| Imaging alloreactive T cells provides early warning of organ transplant rejection | JCI insight | | 2021 | 204 | 84 | ||
| Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance | The journal of clinical investigation | | 2021 | 190 | 137 | ||
| Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients | Bone marrow transplantation | | 2021 | 329 | 2 | ||
| Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects | Blood | | 2021 | 205 | 1 | ||
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | | 2021 | 374 | 116 | ||
| Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD | Blood advances | | 2021 | 128 | 167 | ||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | | 2021 | 350 | 1 | ||
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | | 2021 | 203 | 75 | ||
| Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) | Bulletin du cancer | | 2021 | 230 | 186 | ||
| Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion | Frontiers in Immunology | | 2020 | 251 | 145 | ||
| Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy | Molecular Therapy Oncolytics | | 2020 | 236 | 185 | ||
| Torque Teno Virus as a potential biomarker for complications and survival after allogeneic hematopoietic stem cell transplantation | Frontiers in Immunology | | 2020 | 555 | 166 | ||
| MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors | JCI Insight | | 2020 | 188 | 0 | ||
| Visualization of activated T cells by OX40-immunoPET as a strategy for diagnosis of acute Graft-versus-Host-Disease | Cancer Research | | 2020 | 200 | 167 | ||
| Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease | Frontiers in Immunology | | 2019 | 250 | 240 | ||
| Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway | JCI Insight | | 2019 | 268 | 224 | ||
| Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | | 2019 | 354 | 141 | ||
| Engineered immune cells as highly sensitive cancer diagnostics | Nature Biotechnology | | 2019 | 229 | 1 | ||
| A rare case of immune thrombocytopenia secondary to breast cancer | Clinical Case Reports | | 2019 | 330 | 125 | ||
| Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation | Leukemia and Lymphoma | | 2018 | 542 | 2 | ||
| Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation | BMJ Case Reports | | 2018 | 433 | 1 | ||
| Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome | Bone Marrow Transplantation | | 2018 | 454 | 0 | ||
| Human pegivirus persistence in the human blood virome after allogeneic haematopoietic stem cell transplantation | Clinical Microbiology and Infection | | 2018 | 1,390 | 456 | ||
| Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab | Joint bone spine | | 2017 | 650 | 1 | ||
| Torque Teno Virus Load and Acute Rejection after Orthotopic Liver Transplantation | Transplantation | | 2017 | 834 | 0 | ||
| Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation | Frontiers in Immunology | | 2017 | 257 | 236 | ||
| Syndrome hémophagocytaire réactionnel | Revue médicale suisse | | 2017 | 544 | 318 | ||
| Reversible encephalopathy with photoparoxysmal response during imipenem/cilastatin treatment | Journal of the Neurological Sciences | | 2016 | 354 | 0 | ||
| Modulation of T-bet and Eomes during Maturation of Peripheral Blood NK Cells Does Not Depend on Licensing/Educating KIR | Frontiers in immunology | | 2016 | 558 | 216 | ||
| Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants | Bone marrow transplantation | | 2016 | 674 | 4 | ||
| Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | | 2016 | 511 | 269 | ||
| Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies | Bone marrow transplantation | | 2016 | 505 | 2 | ||
| T-bet and Eomesodermin in NK Cell Development, Maturation, and Function | Frontiers in immunology | | 2016 | 558 | 381 | ||
| Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome | Joint bone spine | | 2015 | 610 | 2 | ||
| Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab | Annals of hematology | | 2015 | 604 | 2 | ||
| NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin | The Journal of immunology | | 2015 | 554 | 3 | ||
| High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection | Journal of virology | | 2014 | 542 | 0 |
